Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Shoulder Innovations, Inc. (SI : NYSE)
 
 • Company Description   
Shoulder Innovations Inc. is a commercial-stage medical technology focused on transforming the shoulder surgical care market. Shoulder Innovations Inc. is based in GRAND RAPIDS, Mich.

Number of Employees: 75

 
 • Price / Volume Information   
Yesterday's Closing Price: $14.60 Daily Weekly Monthly
20 Day Moving Average: 83,716 shares
Shares Outstanding: 20.74 (millions)
Market Capitalization: $302.77 (millions)
Beta:
52 Week High: $17.94
52 Week Low: $10.92
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 11.71% 6.25%
12 Week 8.47% 0.27%
Year To Date 2.10% -2.92%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1535 STEELE AVENUE SW SUITE B
-
GRAND RAPIDS,MI 49507
USA
ph: 616-294-1026
fax: -
ir@shoulderinnovations.com None
 
 • General Corporate Information   
Officers
Robert Ball - Chief Executive Officer and Executive Chairman
Jeffrey Points - Chief Financial Officer
Matthew Ahearn - Director
Richard J. Buchholz - Director
Paul Buckman - Director

Peer Information
Shoulder Innovations, Inc. (CHCR)
Shoulder Innovations, Inc. (ESRX)
Shoulder Innovations, Inc. (MYDP)
Shoulder Innovations, Inc. (COR)
Shoulder Innovations, Inc. (GBCS)
Shoulder Innovations, Inc. (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 82537J108
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/26
Next Expected EPS Date: 09/08/26
Share - Related Items
Shares Outstanding: 20.74
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $302.77 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.46 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.67 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 09/08/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 2.28
Price/Cash Flow: -
Price / Sales: 5.62
EPS Growth
vs. Year Ago Period: 99.21%
vs. Previous Quarter: -7.89%
Sales Growth
vs. Year Ago Period: 64.90%
vs. Previous Quarter: 15.90%
ROE
03/31/26 - -35.11
12/31/25 - -50.24
09/30/25 - -
ROA
03/31/26 - -20.58
12/31/25 - -24.84
09/30/25 - -
Current Ratio
03/31/26 - 11.81
12/31/25 - 11.07
09/30/25 - 11.09
Quick Ratio
03/31/26 - 10.04
12/31/25 - 9.55
09/30/25 - 9.80
Operating Margin
03/31/26 - -55.93
12/31/25 - -55.84
09/30/25 - -
Net Margin
03/31/26 - -81.78
12/31/25 - -85.29
09/30/25 - -
Pre-Tax Margin
03/31/26 - -81.78
12/31/25 - -85.29
09/30/25 - -
Book Value
03/31/26 - 6.41
12/31/25 - 6.83
09/30/25 - 7.26
Inventory Turnover
03/31/26 - 0.63
12/31/25 - 0.77
09/30/25 - -
Debt-to-Equity
03/31/26 - 0.11
12/31/25 - 0.11
09/30/25 - 0.10
Debt-to-Capital
03/31/26 - 10.11
12/31/25 - 9.58
09/30/25 - 9.13
 

Powered by Zacks Investment Research ©